Catalyst Wire Dossier Catalyst Wire Dossier

YHB1411-2

YHB1411-2 · Yuhan Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YHB1411-2, covering 2014-07-10 to 2014-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers [Phase 1]

See pricing